Remote atrial fibrillation management through teleconsultation vs. standard of care: The TeleCheck-AF randomised controlled trial.
- Funded by Netherlands Organisation for Health Research and Development (ZonMW)
- Total publications:0 publications
Grant number: 1.03901E+13
Grant search
Key facts
Disease
COVID-19Start & end year
20212021Funder
Netherlands Organisation for Health Research and Development (ZonMW)Principal Investigator
J. GulpenResearch Location
NetherlandsLead Research Institution
Maastricht UniversityResearch Priority Alignment
N/A
Research Category
Secondary impacts of disease, response & control measures
Research Subcategory
Indirect health impacts
Special Interest Tags
Digital Health
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Due to the COVID-19 pandemic, it is currently not desirable to physically see stable patients with atrial fibrillation in the outpatient clinic. For this reason, a new mHealth infrastructure has been developed at the MUMC+, which enables remote care through app-based heart rate and rhythm monitoring for patients with atrial fibrillation via telephone consultations: TeleCheck-AF. The effectiveness and feasibility of this approach has already been proven, but the cost-effectiveness is still uncertain. For this reason, the aim of this project, set up with various partners, is to investigate whether the TeleCheck-AF approach is as cost-effective as current standard care. The expectation is that the TeleCheck-AF approach will result in a better quality of life and lower costs, because (unnecessary) visits to the outpatient clinic can be avoided.